{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30921214", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "23"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "29"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["e14992", "10.1097/MD.0000000000014992"], "Journal": {"ISSN": "1536-5964", "JournalIssue": {"Volume": "98", "Issue": "13", "PubDate": {"Year": "2019", "Month": "Mar"}}, "Title": "Medicine", "ISOAbbreviation": "Medicine (Baltimore)"}, "ArticleTitle": "Herb induced liver injury after using herbal medicine: A systemic review and case-control study.", "Pagination": {"StartPage": "e14992", "MedlinePgn": "e14992"}, "Abstract": {"AbstractText": ["In Taiwan, traditional herbal medication was included in Taiwan's National Health Insurance (NHI) system since 1996 and in 9 out of 10 hospitals have developed their own departments of traditional medicine. This study aims to address the herb-induced liver injury (HILI) after using herbal medicine on the relationship between age, gender, epidemiology, laboratory data, pathogenesis, mobility, and mortality.We searched the PubMed database with \"hepatitis after herbal medicine\" and \"in human\" till 2018 April and returned 163 articles in a systemic review manner. Two cases reports describing in-vitro liver injury were excluded. Reviews and articles without the detailed report, laboratory data and history were excluded from this study. In the end, there were 53 articles enrolled in this study. These enrolled literatures are from France (n\u200a=\u200a13), Germany (n\u200a=\u200a12), Switzerland (n\u200a=\u200a5) United States of America (n\u200a=\u200a4), Korea (n\u200a=\u200a4), Hong Kong (n\u200a=\u200a4), Greece (n\u200a=\u200a3), China (n\u200a=\u200a2), Canada (n\u200a=\u200a1), Italy (n\u200a=\u200a1), Thailand (n\u200a=\u200a1), Finland (n\u200a=\u200a1), Taiwan (n\u200a=\u200a1), and Japan (n\u200a=\u200a1). The data were analyzed with a commercial statistical software Stata/SE 12.0 program Stata Corporation, College Station, TX, USA. Statistical \u03c7 tests were performed and the significance was set at a P value of less than .05 (2-tailed).The ages are ranged from 15 to 78 years with the mean\u200a\u00b1\u200aSD (standard deviation) of 48.3\u200a\u00b1\u200a16.2 years old. The majority of cases are female (n\u200a=\u200a37). In elderly, man is more commonly seen than female in HILI (37.5% vs 10.5%, P\u200a=\u200a.02). Female is vulnerable to cholestatic type of HILI than male (21.1% vs 0.0%, P\u200a=\u200a.04). Of all the cases in HILI, using pure substance are more commonly seen than mixed substance (P\u200a=\u200a.02). In gender, male patients have higher alanine aminotransferase (GPT) (IU/L) level in HILI than female ones (1560\u200a\u00b1\u200a819 vs 1047\u200a\u00b1\u200a706, P\u200a=\u200a.03).In HILI, the female is more commonly seen than male, but less than male in the elderly. The pure substance more often happens to HILI than mixture substance. Female is predominant in the cholestatic type of HILI. The major prevalence of HILI is in Europe rather than Asia. HILI cases in Europe is 2.75-fold than in Asia. This could be due to fewer reports of the herb induced liver injury in Asia compared to Europe. Prevention of HILI is the best policy, because it needs to take 78\u200a\u00b1\u200a59 days to recover."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Emergency Department and Poison Center, Mackay Memorial Hospital, Taipei City."}], "LastName": "Lin", "ForeName": "Nai-Hui", "Initials": "NH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Emergency Department and Poison Center, Mackay Memorial Hospital, Taipei City."}], "LastName": "Yang", "ForeName": "Hsiu-Wu", "Initials": "HW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Emergency Department and Poison Center, Mackay Memorial Hospital, Taipei City."}, {"Identifier": [], "Affiliation": "Department of Medicine, Mackay Medical College, New Taipei City."}, {"Identifier": [], "Affiliation": "Department of Oral Hygiene, College of Oral Medicine. Taipei Medical University, Taipei."}, {"Identifier": [], "Affiliation": "Yuanpei University of Medical Technology, Hsinchu."}], "LastName": "Su", "ForeName": "Yu-Jang", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Mackay Medical College, New Taipei City."}, {"Identifier": [], "Affiliation": "Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital."}, {"Identifier": [], "Affiliation": "MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan."}], "LastName": "Chang", "ForeName": "Chen-Wang", "Initials": "CW"}], "PublicationTypeList": ["Journal Article", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Medicine (Baltimore)", "NlmUniqueID": "2985248R", "ISSNLinking": "0025-7974"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Young Adult"}, {"QualifierName": [], "DescriptorName": "Age Factors"}, {"QualifierName": [], "DescriptorName": "Case-Control Studies"}, {"QualifierName": ["epidemiology", "pathology"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Sex Factors"}, {"QualifierName": [], "DescriptorName": "Taiwan"}], "CoiStatement": "The authors have no funding and conflicts of interest to disclose."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2013;4:177.", "ArticleIdList": ["PMC3887317", "24454289"]}, {"Citation": "Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis 2014;34:172\u201393.", "ArticleIdList": ["24879982"]}, {"Citation": "Chen KC, Lu R, Iqbal U, et al. Interactions between traditional chinese medicine and western drugs in Taiwan: a population-based study. Comput Methods Programs Biomed 2015;122:462\u201370.", "ArticleIdList": ["26470816"]}, {"Citation": "Teschke R. Traditional Chinese medicine induced liver injury. J Clin Transl Hepatol 2014;2:80\u201394.", "ArticleIdList": ["PMC4521264", "26357619"]}, {"Citation": "Frenzel C, Teschke R. Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci 2016;17: pii: E588.", "ArticleIdList": ["PMC4881436", "27128912"]}, {"Citation": "de Boer YS, Sherker AH. Herbal and dietary supplement\u2013induced liver, injury. Clin Liver Dis 2017;21:135\u201349.", "ArticleIdList": ["PMC5117680", "27842768"]}, {"Citation": "Teschke R, Schwarzenboeck A, Eickhoff A, et al. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf 2013;12:339\u201366.", "ArticleIdList": ["23458441"]}, {"Citation": "Raschi E, De Ponti F. Drug- and herb-induced liver injury: progress, current challenges and emerging signals of post-marketing risk. World J Hepatol 2015;7:1761\u201371.", "ArticleIdList": ["PMC4491905", "26167249"]}, {"Citation": "Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology 2014;146:914\u201328.", "ArticleIdList": ["PMC4031195", "24389305"]}, {"Citation": "Chalasani N, Bj\u00f6rnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010;138:2246\u201359.", "ArticleIdList": ["PMC3157241", "20394749"]}, {"Citation": "Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. drug-induced liver injury network. Hepatology 2014;60:1399\u2013408.", "ArticleIdList": ["PMC4293199", "25043597"]}, {"Citation": "Zheng EX, Navarro VJ. Liver injury from herbal, dietary, and weight loss supplements: a review. J Clin and Transl Hepatol 2015;3:93\u20138.", "ArticleIdList": ["PMC4548352", "26357638"]}, {"Citation": "Cho JH, Oh DS, Hong SH, et al. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol 2017;91:4009\u201315.", "ArticleIdList": ["PMC5719126", "28634823"]}, {"Citation": "Bj\u00f6rnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005;42:481\u20139.", "ArticleIdList": ["16025496"]}, {"Citation": "Shapiro MA, Lewis JH. Causality assessment of drug induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 2007;11:477\u2013505.", "ArticleIdList": ["17723916"]}, {"Citation": "Zhou Y, Yang L, Liao Z, et al. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol 2013;25:825\u20139.", "ArticleIdList": ["23510965"]}, {"Citation": "Melchart D, Linde K, Weidenhammer W, et al. Liver enzyme elevations in patients treated with traditional Chinese medicine. JAMA 1999;282:28\u20139.", "ArticleIdList": ["10404907"]}, {"Citation": "Lee BM, Lee WC, Jang JY, et al. Clinical features of drug-induced liver injury according to etiology. J Korean Med Sci 2015;30:1815\u201320.", "ArticleIdList": ["PMC4689826", "26713057"]}, {"Citation": "Wai CT, Tan BH, Chan CL, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007;27:465\u201374.", "ArticleIdList": ["17403186"]}, {"Citation": "Navarro VJ, Khan I, Bj\u00f6rnsson E, et al. Liver injury from herbal and dietary supplements. Hepatology 2017;65:363\u201373.", "ArticleIdList": ["PMC5502701", "27677775"]}, {"Citation": "Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci 2015;17: ii:E14.", "ArticleIdList": ["PMC4730261", "26712744"]}, {"Citation": "Daly AK, Donaldson PT, Bhatnagar P, et al. HLA-B\u22175701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009;41:816\u20139.", "ArticleIdList": ["19483685"]}, {"Citation": "Orkin C, Wang J, Bergin C, et al. An epidemiologic study to determine the prevalence of the HLA-B\u22175701 allele among HIV-positive patients in Europe. Pharmacogenet Genomics 2010;20:307\u201314.", "ArticleIdList": ["20375757"]}, {"Citation": "Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol 2015;6:72.", "ArticleIdList": ["PMC4407580", "25954198"]}, {"Citation": "Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Gastroenterology 1999;117:1234\u20137.", "ArticleIdList": ["10535888"]}, {"Citation": "Huxtable RJ. The harmful potential of herbal and other plant products. Drug Saf 1990;5Suppl 1:126\u201336.", "ArticleIdList": ["2182056"]}, {"Citation": "Suk KT, Kim DJ, Kim CH, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 2012;107:1380\u20137.", "ArticleIdList": ["22733303"]}, {"Citation": "Russmann S, Kaye JA, Jick SS, et al. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database. Br J Clin Pharmacol 2005;60:76\u201382.", "ArticleIdList": ["PMC1884907", "15963097"]}, {"Citation": "Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924\u201334.", "ArticleIdList": ["PMC3654244", "18955056"]}, {"Citation": "Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008;66:758\u201366.", "ArticleIdList": ["PMC2675778", "19032721"]}, {"Citation": "Teschke R, Qiu SX, Lebot V. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis 2011;43:676\u201381.", "ArticleIdList": ["21377431"]}, {"Citation": "Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009;16:3041\u201353.", "ArticleIdList": ["PMC2765083", "19689281"]}, {"Citation": "Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474\u201385.", "ArticleIdList": ["12890847"]}, {"Citation": "Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166\u201376.", "ArticleIdList": ["11812920"]}, {"Citation": "Moro PA, Cassetti F, Giugliano G, et al. Hepatitis from Greater celandine (Chelidonium majus L.): review of literature and report of a new case. J Ethnopharmacol 2009;124:328\u201332.", "ArticleIdList": ["19397968"]}, {"Citation": "Hardeman E, Van Overbeke L, Ilegems S, et al. Acute hepatitis induced by greater celandine (Chelidonium majus). Acta Gastroenterol Belg 2008;71:281\u20132.", "ArticleIdList": ["18720945"]}, {"Citation": "Rifai K, Flemming P, Manns MP, et al. Severe drug hepatitis caused by Chelidonium. Internist (Berl) 2006;47:749\u201351.", "ArticleIdList": ["16645871"]}, {"Citation": "Stickel F, Poschl G, Seitz HK, et al. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol 2003;38:565\u20138.", "ArticleIdList": ["12795472"]}, {"Citation": "Crijns AP, de Smet PA, van den Heuvel M, et al. Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus). Ned Tijdschr Geneeskd 2002;146:124\u20138.", "ArticleIdList": ["11826672"]}, {"Citation": "Colombo ML, Bosisio E. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacol Res 1996;33:127\u201334.", "ArticleIdList": ["8870028"]}, {"Citation": "Teschke R, Frenzel C, Glass X, et al. Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol 2012;11:838\u201348.", "ArticleIdList": ["23109446"]}, {"Citation": "Korth C. Drug-induced hepatotoxicity of select herbal therapies. J Pharm Pract 2014;27:567\u201372.", "ArticleIdList": ["25546878"]}, {"Citation": "Menichini F, Conforti F, Rigano D, et al. Phytochemical composition, anti-inflammatory and antitumour activities of four Teucrium essential oils from Greece. Food Chem 2009;115:679\u201386."}, {"Citation": "Hasani-Ranjbar S, Nayebi N, Larijani B, et al. A systematic review of the efficacy and safety of Teucrium species; from anti-oxidant to anti-diabetic effects. Int J Pharmacol 2010;6:315\u201325."}, {"Citation": "Gori L, Galluzzi P, Mascherini V, et al. Two contemporary cases of hepatitis associated with Teucrium chamaedrys L. decoction use: case reports and review of literature. Basic Clin Pharmacol Toxicol 2011;109:521\u20136.", "ArticleIdList": ["21848806"]}, {"Citation": "Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117:129\u201332.", "ArticleIdList": ["1605427"]}, {"Citation": "Mostefa-Kara N, Pauwels A, Pines E, et al. Fatal hepatitis after herbal tea. Lancet 1992;340:674.", "ArticleIdList": ["1355234"]}, {"Citation": "Laliberte L, Villeneuve JP. Hepatitis after the use of germander, a herbal remedy. CMAJ 1996;154:1689\u201392.", "ArticleIdList": ["PMC1487903", "8646656"]}, {"Citation": "Castot A, Larrey D. Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterol Clin Biol 1992;16:916\u201322.", "ArticleIdList": ["1493896"]}, {"Citation": "Cupp MJ. Toxicology and clinical pharmacology of herbal products, Forensic science and medicine. 2000;Totowa: Humana Press, 177 p."}, {"Citation": "Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997;157:913\u20139.", "ArticleIdList": ["9129552"]}, {"Citation": "Agarwal R, Wang ZY, Bik DP, et al. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos 1991;19:620\u20134.", "ArticleIdList": ["1680628"]}, {"Citation": "Capdevila J, Gil L, Orellana M, et al. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys 1988;261:257\u201363.", "ArticleIdList": ["3128168"]}, {"Citation": "Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990;12:203\u20136.", "ArticleIdList": ["2324485"]}, {"Citation": "Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. In: Hepatic Metabolism of Foreign Compounds. Lippincott Williams & Wilkins; 1999, 11\u201340."}, {"Citation": "Lucena MI, Andrade RJ, Kaplowitz N, et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology 2009;49:2001\u20139.", "ArticleIdList": ["19475693"]}, {"Citation": "Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Intern Med 2001;135(8 Pt 1):594\u2013600.", "ArticleIdList": ["11601931"]}, {"Citation": "Hoofnagle JH, Serrano J, Knoben JE, et al. LiverTox: a website on drug-induced liver injury. Hepatology 2013;57:873\u20134.", "ArticleIdList": ["PMC5044298", "23456678"]}]}], "History": [{"Year": "2019", "Month": "3", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30921214", "PMC6456154", "10.1097/MD.0000000000014992", "00005792-201903290-00040"]}}]}